Found: 7
Select item for more details and to access through your institution.
COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00202-9
- By:
- Publication type:
- Article
Triplet Therapy with PD-1 Blockade, Histone Deacetylase Inhibitor, and DNA Methyltransferase Inhibitor Achieves Radiological Response in Refractory Double-Expressor Diffuse Large B-cell Lymphoma with 17p Deletion.
- Published in:
- Case Reports in Hematology, 2020, p. 1, doi. 10.1155/2020/8879448
- By:
- Publication type:
- Article
Increased Expression of TIGIT/CD57 in Peripheral Blood/Bone Marrow NK Cells in Patients with Chronic Myeloid Leukemia.
- Published in:
- BioMed Research International, 2020, v. 2020, p. 1, doi. 10.1155/2020/9531549
- By:
- Publication type:
- Article
PD-1 and TIGIT Are Highly Co-Expressed on CD8<sup>+</sup> T Cells in AML Patient Bone Marrow.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.686156
- By:
- Publication type:
- Article
Clinical and laboratory features of seven patients with acute myeloid leukemia (AML)-M2/M3 and elevated myeloblasts and abnormal promyelocytes.
- Published in:
- Cancer Cell International, 2014, v. 14, n. 1, p. 1, doi. 10.1186/s12935-014-0111-y
- By:
- Publication type:
- Article
D-CAG (decitabine followed by cytarabine, aclarubicin, and G-CSF) for relapsed acute myeloid leukemia after hematopoietic cell transplantation.
- Published in:
- 2016
- By:
- Publication type:
- case study
Cytokine-induced killer cell therapy for modulating regulatory T cells in patients with non-small cell lung cancer.
- Published in:
- Experimental & Therapeutic Medicine, 2017, v. 14, n. 1, p. 831, doi. 10.3892/etm.2017.4562
- By:
- Publication type:
- Article